Here's Why You Should Add ALNY Stock to Your Portfolio Right Now

Alnylam Pharmaceuticals (ALNY) focuses on developing novel therapeutics based on RNAi technology. The company’s pipeline of experimental RNAi therapeutics is focused on three strategic therapeutic areas — genetic medicines, cardio-metabolic disease and hepatic infectious disease. Alnylam’s marketed portfolio of drugs comprises Amvuttra (vutrisiran), Givlaari (givosiran), Oxlumo (lumasiran) and Onpattro (patisiran).Let’s delve deeper to discuss four reasons why adding Alnylam stock to your portfolio may prov ...